Skip to main content

Signature Genomic Licenses Affy Patents for Comparative Genomics Studies

NEW YORK, Feb. 14 (GenomeWeb News) - Signature Genomic Laboratories has licensed an undisclosed number of Affymetrix patents related to the use of microarrays for comparative genomic hybridization studies, Signature said today.


The license will be applied to Signature Genomic's SignatureChip microarray-based diagnostics for cytogenic abnormalities, the company said.


Additional details of the licensing agreement were not disclosed.

The Scan

Call to Look Again

More than a dozen researchers penned a letter in Science saying a previous investigation into the origin of SARS-CoV-2 did not give theories equal consideration.

Not Always Trusted

In a new poll, slightly more than half of US adults have a great deal or quite a lot of trust in the Centers for Disease Control and Prevention, the Hill reports.

Identified Decades Later

A genetic genealogy approach has identified "Christy Crystal Creek," the New York Times reports.

Science Papers Report on Splicing Enhancer, Point of Care Test for Sexual Transmitted Disease

In Science this week: a novel RNA structural element that acts as a splicing enhancer, and more.